{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:49:26Z","timestamp":1788731366074,"version":"build-2803163510"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["General Program; No.81973798"],"award-info":[{"award-number":["General Program; No.81973798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["General Program; No.81973798"],"award-info":[{"award-number":["General Program; No.81973798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["General Program; No.81973798"],"award-info":[{"award-number":["General Program; No.81973798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["General Program; No.81973798"],"award-info":[{"award-number":["General Program; No.81973798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["General Program; No.81973798"],"award-info":[{"award-number":["General Program; No.81973798"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No.75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No.75"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No.75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No.75"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No.75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No.75"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine","award":["National Medical Education Letter [2022] No.75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No.75"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023065"],"award-info":[{"award-number":["zyyzdxk-2023065"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023065"],"award-info":[{"award-number":["zyyzdxk-2023065"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023065"],"award-info":[{"award-number":["zyyzdxk-2023065"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023065"],"award-info":[{"award-number":["zyyzdxk-2023065"]}]},{"name":"High level Key Discipline Construction Project of Traditional Chinese Medicine of the State Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023065"],"award-info":[{"award-number":["zyyzdxk-2023065"]}]},{"name":"Construction Project of National Famous Traditional Chinese Medicine Expert Inheritance Studio by the State Administration of Traditional Chinese Medicine,","award":["National Medical Education Letter [2022] No.75"],"award-info":[{"award-number":["National Medical Education Letter [2022] No.75"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>For more than 30 years, Qian Ji Sheng Xue Pian (QJSXP) has been used clinically to treat primary immune thrombocytopenia (ITP) with good documented efficacy. However, nothing is known about its underlying mechanisms, effective components, and possible targets. To employ several methodologies to initially investigate the possible targets and therapeutic mechanisms of QJSXP in the treatment of ITP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Liquid chromatography-mass spectrometry (LC-MS) identified the principal chemical elements of QJSXP and assessed its probable active components based on ADME characteristics. The research incorporated multidimensional databases to pinpoint probable targets for the active components. Key pathogenic targets linked to ITP were aggregated from several illness databases, and the STRING and Metascape tools were utilized to examine protein interaction activities and related biological processes. Mendelian randomization (MR) was then utilized to determine beneficial targets for the therapy of ITP. The potential targets, including disease targets and MR-positive targets, were found at the intersection, while risk genes were excluded by heterogeneity, pleiotropy, and Steiger analysis to ascertain the core targets. Molecular docking and molecular dynamics simulations were conducted utilizing Schrodinger and Gromacs software to assess the binding affinity of compound-core targets. The toxicological effects of active molecules targeting critical sites were concurrently anticipated using several toxicity databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 67 active components and 352 potential targets were discovered in QJSXP, of which 77 were associated with ITP disease targets. Through MR analysis, a total of 12 core genes were identified. Binding scores below \u2212\u20094.25\u00a0kcal\/mol constituted 82.0%; docking scores below \u2212\u20095\u00a0kcal\/mol represented 60.1%, with an average binding energy of -5.44\u00a0kcal\/mol. The majority of targets demonstrated strong binding affinity with the components. Toxicity prediction initially highlighted potential hazards, including hepatotoxicity and nephrotoxicity, establishing a foundation for future clinical surveillance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study has preliminarily identified the active constituents, associated pathways, and possible targets of QJSXP in the treatment of ITP, offering insights for additional experimental validation of QJSXP\u2019s mechanism of action in ITP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00620-3","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:57:23Z","timestamp":1765007843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multimethodological and multiscale investigation of the therapeutic mechanism of Qian Ji Sheng Xue Pian in treating primary immune thrombocytopenia"],"prefix":"10.1186","volume":"163","author":[{"given":"Yujue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"issue":"1","key":"620_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01401-z","volume":"16","author":"XG Liu","year":"2023","unstructured":"Liu XG, Hou Y, Hou M. How we treat primary immune thrombocytopenia in adults. J Hematol Oncol. 2023;16(1):4.","journal-title":"J Hematol Oncol"},{"key":"620_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.thromres.2020.01.020","volume":"187","author":"R Boulware","year":"2020","unstructured":"Boulware R, Refaai MA. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia? Thromb Res. 2020;187:154\u20138.","journal-title":"Thromb Res"},{"issue":"8","key":"620_CR3","first-page":"617","volume":"41","author":"H Ming","year":"2020","unstructured":"Ming H, Yu H. Chinese guidelines for the diagnosis and treatment of primary immune thrombocytopenia in adults (2020 Edition). Chin J Hematol. 2020;41(8):617\u201323.(in Chinese)","journal-title":"Chin J Hematol"},{"key":"620_CR4","unstructured":"Zhu WW, Chen XY, Zhou YM. Traditional Chinese medicine expert consensus on the diagnosis and management of adult primary immune thrombocytopenia. China J Tradit Chin Med Pharm. 2022;37(04):2129\u201333. (in Chinese)"},{"issue":"2","key":"620_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016","volume":"6","author":"A Zufferey","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017;6(2):16.","journal-title":"J Clin Med"},{"issue":"22","key":"620_CR6","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","volume":"124","author":"G Moulis","year":"2014","unstructured":"Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124(22):3308\u201315.","journal-title":"Blood"},{"key":"620_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.thromres.2017.05.010","volume":"155","author":"JY Lee","year":"2017","unstructured":"Lee JY, Lee JH, Lee H, Kang B, Kim JW, Kim SH, et al. Epidemiology and management of primary immune thrombocytopenia: a nationwide population-based study in Korea. Thromb Res. 2017;155:86\u201391.","journal-title":"Thromb Res"},{"key":"620_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/CIA.S369574","volume":"18","author":"E Crickx","year":"2023","unstructured":"Crickx E, Mah\u00e9vas M, Michel M, Godeau B. Older adults and immune thrombocytopenia: considerations for the clinician. Clin Interv Aging. 2023;18:115\u201330.","journal-title":"Clin Interv Aging"},{"issue":"7","key":"620_CR9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3390\/medicina60071153","volume":"60","author":"G Pekta\u015f","year":"2024","unstructured":"Pekta\u015f G, Uncu \u0130A, Dere Y, \u00d6nc\u00fc \u015e, K\u0131z\u0131lkaya MB, Sadi G, et al. Retrospective evaluation of survival and prognostic factors in immune thrombocytopenia: a single-center and cross-sectional study. Medicina (Kaunas). 2024;60(7):1153.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"620_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","volume":"2015","author":"DM Arnold","year":"2015","unstructured":"Arnold DM. Bleeding complications in immune thrombocytopenia. Hematology. 2015;2015(1):237\u201342.","journal-title":"Hematology"},{"issue":"23","key":"620_CR11","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, et al. American society of hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3(23):3829\u201366.","journal-title":"Blood Adv"},{"key":"620_CR12","unstructured":"Huang ZQ, Zhou YM, Xue ZZ, Yao CF, Huang SL, Wu YM et al. Clinical study on primary treatment of idiopathic thrombo-cytopenic purpura with shengxueling. Chin J Traditional Med Sci Technol. 1996;(01):14\u201315. (in Chinese)"},{"key":"620_CR13","unstructured":"Xue ZZ, Chen F, Zhou YM, Huang ZQ, He W. Exploration of hemostatic mechanism of blood-generating decoctiontreating primary thrombcytopenic purpura. Shanghai J Traditional Chin Med. 1999;(10):19\u201320. (in Chinese)"},{"issue":"6","key":"620_CR14","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3736\/jcim20040605","volume":"2","author":"YM Zhou","year":"2004","unstructured":"Zhou YM, Hu MH, Yang JM, Zhu WW, Huang ZQ, Zhou SH, et al. Clinical study on idiopathic thrombocytopenic purpura treated with shengxueling granule. J Chin Integr Med. 2004;2(6):421\u20135. (in Chinese).","journal-title":"J Chin Integr Med"},{"issue":"12","key":"620_CR15","first-page":"46","volume":"45","author":"JZ Bao","year":"2011","unstructured":"Bao JZ, Zhao XH, Zhou YM, Zhu WW,Lu JH,Hu MH, et al. Clinical study on idiopathic thrombocytopenic purpura treated with shengxueling granule. Shanghai J Traditional Chin Med. 2011;45(12):46\u20138. (in Chinese).","journal-title":"Shanghai J Traditional Chin Med"},{"key":"620_CR16","unstructured":"Xu HT. Observation on the efficacy of shengxueling in treating immune thrombocytopenia and its effect on intestinal flora [master\u2032s thesis]. Shanghai:Shanghai University of Traditional Chinese Medicine. 2019. (in Chinese)"},{"key":"620_CR17","unstructured":"Zhu WW, Zhou YM, Xue ZZ, Hu MH, He W. Th1\/Th2 subset responses of peripheral blood mononuclear cells in chronic immune thrombocytopenia (ITP) and intervention of shengxueling. Mod J Integr Traditional Chin Western Med. 2008;(33):5120\u2013 5121.\u00a0(in Chinese)"},{"key":"620_CR18","unstructured":"Zhou YM, Xue ZZ, Yao CF, Zhang T, Zhang QM, Huang ZQ et al. Effect of shengxueling on megakaryocyte progenitor cells cultured in vitro from bone marrow of patients with idiopathic thrombocytopenic purpura. Chin J Integr Traditional Western Med.1991,(01):23-24+4-5.(in Chinese)"},{"key":"620_CR19","unstructured":"Huang ZQ, Zhou YM, Yao CF, Xue ZZ, Lu JY, Zhan WY et al. Clinical study on idiopathic thrombocytopenic purpura. China J Traditional Chin Med Pharm. 1993;(02):11\u201314.\u00a0(in Chinese)"},{"issue":"02","key":"620_CR20","first-page":"43","volume":"44","author":"WW Zhu","year":"2010","unstructured":"Zhu WW, Zhou YM, Yuan NR, He W, Xue ZZ. GR subtype expressions in patients with idiopathic throbocytopenic purpura and its treatment with \u201cshengxueling\u201d Shanghai Journal of Traditional Chinese Medicine. Shanghai J Tradit Chin Med. 2010;44(02):43\u20135.(in Chinese)","journal-title":"Shanghai J Tradit Chin Med"},{"key":"620_CR21","unstructured":"Jian C. Discussion on mechanism of hemorrhage and blood coagulation of Shihui powder. J Shandong Univ Traditional Chin Med. 2004;(06):463\u2013466.\u00a0(in Chinese)"},{"issue":"2","key":"620_CR22","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110\u201320.","journal-title":"Chin J Nat Med"},{"issue":"1","key":"620_CR23","volume":"2013","author":"GB Zhang","year":"2013","unstructured":"Zhang GB, Li QY, Chen QL, Su SB. Network pharmacology: a new approach for Chinese herbal medicine research. Evid Based Complement Alternat Med. 2013;2013(1):621423.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"620_CR24","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255.","journal-title":"Nat Commun"},{"issue":"6","key":"620_CR25","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/ije\/dyx207","volume":"46","author":"VM Walker","year":"2017","unstructured":"Walker VM, Davey Smith G, Davies NM, Martin RM. Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities. Int J Epidemiol. 2017;46(6):2078\u201389.","journal-title":"Int J Epidemiol"},{"key":"620_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184331","author":"L Pinzi","year":"2019","unstructured":"Pinzi L, Rastelli G. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20184331.","journal-title":"Int J Mol Sci"},{"key":"620_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151575","volume":"756","author":"R Singh","year":"2025","unstructured":"Singh R, Purohit R. Determining the effect of natural compounds on mutations of pyrazinamidase in multidrug-resistant tuberculosis: illuminating the dark tunnel. Biochem Biophys Res Commun. 2025;756:151575.","journal-title":"Biochem Biophys Res Commun"},{"key":"620_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151614","volume":"758","author":"B Sharma","year":"2025","unstructured":"Sharma B, Purohit R. Enhanced sampling simulations to explore himalayan phytochemicals as potential phosphodiesterase-1 inhibitor for neurological disorders. Biochem Biophys Res Commun. 2025;758:151614.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"620_CR29","doi-asserted-by":"publisher","first-page":"10150","DOI":"10.3390\/molecules190710150","volume":"19","author":"SZ Grinter","year":"2014","unstructured":"Grinter SZ, Zou X. Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design. Molecules. 2014;19(7):10150\u201376.","journal-title":"Molecules"},{"issue":"D1","key":"620_CR30","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2024","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2025 update. Nucleic Acids Res. 2024;53(D1):D1516\u201325.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"620_CR31","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.","journal-title":"Sci Rep"},{"issue":"9","key":"620_CR32","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1021\/jm0492002","volume":"48","author":"YC Martin","year":"2005","unstructured":"Martin YC. A bioavailability score. J Med Chem. 2005;48(9):3164\u201370.","journal-title":"J Med Chem"},{"issue":"W1","key":"620_CR33","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"620_CR34","doi-asserted-by":"publisher","first-page":"W356","DOI":"10.1093\/nar\/gkx374","volume":"45","author":"X Wang","year":"2017","unstructured":"Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356\u201360.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"620_CR35","doi-asserted-by":"publisher","first-page":"W26","DOI":"10.1093\/nar\/gku477","volume":"42","author":"J Nickel","year":"2014","unstructured":"Nickel J, Gohlke BO, Erehman J, Banerjee P, Rong WW, Goede A, et al. SuperPred: update on drug classification and target prediction. Nucleic Acids Res. 2014;42(W1):W26\u201331.","journal-title":"Nucleic Acids Res"},{"key":"620_CR36","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baq020","author":"M Safran","year":"2010","unstructured":"Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. GeneCards version 3: the human gene integrator. Database. 2010. https:\/\/doi.org\/10.1093\/database\/baq020.","journal-title":"Database"},{"issue":"1","key":"620_CR37","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/cpbi.27","volume":"58","author":"JS Amberger","year":"2017","unstructured":"Amberger JS, Hamosh A. Searching online Mendelian inheritance in man (OMIM): a knowledgebase of human genes and genetic phenotypes. Curr Protocols Bioinf. 2017;58(1):121\u2013212.","journal-title":"Curr Protocols Bioinf"},{"issue":"D1","key":"620_CR38","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2017","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2017;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"620_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ng0504-431","volume":"36","author":"KG Becker","year":"2004","unstructured":"Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database. Nat Genet. 2004;36(5):431\u20132.","journal-title":"Nat Genet"},{"issue":"D1","key":"620_CR40","doi-asserted-by":"publisher","first-page":"D833","DOI":"10.1093\/nar\/gkw943","volume":"45","author":"J Pi\u00f1ero","year":"2016","unstructured":"Pi\u00f1ero J, Bravo \u00c0, Queralt-Rosinach N, Guti\u00e9rrez-Sacrist\u00e1n A, Deu-Pons J, Centeno E, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2016;45(D1):D833\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"620_CR41","doi-asserted-by":"publisher","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","volume":"49","author":"S Fang","year":"2020","unstructured":"Fang S, Dong L, Liu L, Guo J, Zhao L, Zhang J, et al. HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res. 2020;49(D1):D1197\u2013206.","journal-title":"Nucleic Acids Res"},{"key":"620_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2019.103613","volume":"213","author":"M Soudy","year":"2020","unstructured":"Soudy M, Anwar AM, Ahmed EA, Osama A, Ezzeldin S, Mahgoub S, et al. UniprotR: retrieving and visualizing protein sequence and functional information from universal protein resource (UniProt knowledgebase). J Proteomics. 2020;213:103613.","journal-title":"J Proteomics"},{"issue":"D1","key":"620_CR43","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2018","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"620_CR44","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"1","key":"620_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Bou\u00e7as J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.","journal-title":"Genome Biol"},{"issue":"9","key":"620_CR46","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"D1","key":"620_CR47","doi-asserted-by":"publisher","first-page":"D998","DOI":"10.1093\/nar\/gkae1070","volume":"53","author":"M Cerezo","year":"2024","unstructured":"Cerezo M, Sollis E, Ji Y, Lewis E, Abid A, Bircan Karatu\u011f O, et al. The NHGRI-EBI GWAS catalog: standards for reusability, sustainability and diversity. Nucleic Acids Res. 2024;53(D1):D998\u20131005.","journal-title":"Nucleic Acids Res"},{"key":"620_CR48","unstructured":"Schr\u00f6dinger. Release 2025-2: Maestro, Schr\u00f6dinger, LLC, New York, NY, 2025."},{"issue":"11","key":"620_CR49","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem. 2008;29(11):1859\u201365.","journal-title":"J Comput Chem"},{"issue":"43","key":"620_CR50","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L. Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. J Phys Chem A. 2001;105(43):9954\u201360.","journal-title":"J Phys Chem A"},{"issue":"W1","key":"620_CR51","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","volume":"52","author":"P Banerjee","year":"2024","unstructured":"Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024;52(W1):W513\u201320.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"620_CR52","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. PkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u201372.","journal-title":"J Med Chem"},{"issue":"W1","key":"620_CR53","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L, Shi S, Yi J, Wang N, He Y, Wu Z, et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024;52(W1):W422\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"620_CR54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0968-0004(00)89005-2","volume":"20","author":"CJ Sherr","year":"1995","unstructured":"Sherr CJ. D-type cyclins. Trends Biochem Sci. 1995;20(5):187\u201390.","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"620_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1747-1028-1-32","volume":"1","author":"K Yang","year":"2006","unstructured":"Yang K, Hitomi M, Stacey DW. Variations in cyclin D1 levels through the cell cycle determine the proliferative fate of a cell. Cell Div. 2006;1(1):32.","journal-title":"Cell Div"},{"issue":"10","key":"620_CR56","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1182\/blood.V86.10.3783.bloodjournal86103783","volume":"86","author":"Z Wang","year":"1995","unstructured":"Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis. Blood. 1995;86(10):3783\u20138.","journal-title":"Blood"},{"issue":"8","key":"620_CR57","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1073\/pnas.080068597","volume":"97","author":"M Majewski","year":"2000","unstructured":"Majewski M, Korecka M, Kossev P, Li S, Goldman J, Moore J, et al. The immunosuppressive macrolide RAD inhibits growth of human epstein\u2013barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders. Proc Natl Acad Sci U S A. 2000;97(8):4285\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"620_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00627-y","volume":"6","author":"HY Zhao","year":"2021","unstructured":"Zhao HY, Zhang YY, Xing T, Tang SQ, Wen Q, Lyu ZS, et al. M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity. Signal Transduct Target Ther. 2021;6(1):234.","journal-title":"Signal Transduct Target Ther"},{"key":"620_CR59","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1538-7836.2009.03419.x","volume":"7","author":"K Kaushansky","year":"2009","unstructured":"Kaushansky K. Molecular mechanisms of thrombopoietin signaling. J Thromb Haemost. 2009;7:235\u20138.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"620_CR60","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.thromres.2014.11.042","volume":"135","author":"XL Zhang","year":"2015","unstructured":"Zhang XL, Ma J, Xu M, Meng F, Qu M, Sun J, et al. Imbalance between CD205 and CD80\/CD86 in dendritic cells in patients with immune thrombocytopenia. Thromb Res. 2015;135(2):352\u201361.","journal-title":"Thromb Res"},{"issue":"7","key":"620_CR61","first-page":"89","volume":"60","author":"YJ Xiang","year":"2022","unstructured":"Xiang YJ, Liu Q, Liu L, Shi Y. Mechanism of abnormal immune response of dendritic cells in immune thrombocytopenia. J Shandong Univ (Health Sciences). 2022;60(7):89\u201397.","journal-title":"J Shandong Univ (Health Sciences)"},{"key":"620_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.intimp.2016.05.002","volume":"38","author":"Y Lin","year":"2016","unstructured":"Lin Y, Zhou X, Guo W, Li Q, Pan X, Bao Y, et al. RhIL-11 treatment normalized Th1\/Th2 and T-bet\/GATA-3 imbalance in in human immune thrombocytopenic purpura (ITP). Int Immunopharmacol. 2016;38:40\u20134.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"620_CR63","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","volume":"16","author":"S Audia","year":"2017","unstructured":"Audia S, Mah\u00e9vas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16(6):620\u201332.","journal-title":"Autoimmun Rev"},{"key":"620_CR64","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.biopha.2018.05.072","volume":"104","author":"L Li","year":"2018","unstructured":"Li L, Wan G, Han B, Zhang Z. Echinacoside alleviated LPS-induced cell apoptosis and inflammation in rat intestine epithelial cells by inhibiting the mTOR\/STAT3 pathway. Biomed Pharmacother. 2018;104:622\u20138.","journal-title":"Biomed Pharmacother"},{"key":"620_CR65","first-page":"167","volume":"64","author":"J Wojas","year":"2010","unstructured":"Wojas J, Pajtasz-Piasecka E. Dendritic cell-regulatory t-cell interaction. Postepy Hig Med Dosw (Online). 2010;64:167\u201374.","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"3","key":"620_CR66","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1124\/jpet.106.109058","volume":"319","author":"S Braselmann","year":"2006","unstructured":"Braselmann S, Taylor V, Zhao H, Wang S, Sylvain C, Baluom M, et al. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J Pharmacol Exp Ther. 2006;319(3):998\u20131008.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"620_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2217\/imt-2017-0097","volume":"10","author":"A Newland","year":"2018","unstructured":"Newland A, Lee EJ, McDonald V, Bussel JB. Fostamatinib for persistent\/chronic adult immune thrombocytopenia. Immunotherapy. 2018;10(1):9\u201325.","journal-title":"Immunotherapy"},{"issue":"14","key":"620_CR68","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2008-07-166439","volume":"113","author":"A Podolanczuk","year":"2009","unstructured":"Podolanczuk A, Lazarus AH, Crow AR, Grossbard E, Bussel JB. Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood. 2009;113(14):3154\u201360.","journal-title":"Blood"},{"issue":"7","key":"620_CR69","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/ajh.25125","volume":"93","author":"J Bussel","year":"2018","unstructured":"Bussel J, Arnold DM, Grossbard E, Mayer J, Treli\u0144ski J, Homenda W, et al. <article-title update=\"added\">Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo\u2010controlled trials. Am J Hematol. 2018;93(7):921\u201330.","journal-title":"Am J Hematol"},{"issue":"6","key":"620_CR70","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.4049\/jimmunol.164.6.3123","volume":"164","author":"SR Brooks","year":"2000","unstructured":"Brooks SR, Li X, Volanakis EJ, Carter RH. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines1. J Immunol. 2000;164(6):3123\u201331.","journal-title":"J Immunol"},{"issue":"1","key":"620_CR71","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S1074-7613(00)00007-8","volume":"13","author":"M Fujimoto","year":"2000","unstructured":"Fujimoto M, Fujimoto Y, Poe JC, Jansen PJ, Lowell CA, DeFranco AL, et al. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity. 2000;13(1):47\u201357.","journal-title":"Immunity"},{"issue":"5110","key":"620_CR72","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1126\/science.7684160","volume":"260","author":"DA Tuveson","year":"1993","unstructured":"Tuveson DA, Carter RH, Soltoff SP, Fearon DT. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science. 1993;260(5110):986\u20139.","journal-title":"Science"},{"key":"620_CR73","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230683","author":"Z Qin","year":"2024","unstructured":"Qin Z, Wang R, Hou P, Zhang Y, Yuan Q, Wang Y, et al. TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation. J Exp Med. 2024. https:\/\/doi.org\/10.1084\/jem.20230683.","journal-title":"J Exp Med"},{"issue":"9","key":"620_CR74","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/intimm\/dxn076","volume":"20","author":"L Tian","year":"2008","unstructured":"Tian L, Wu X, Chi C, Han M, Xu T, Zhuang Y. ADAM10 is essential for proteolytic activation of Notch during thymocyte development. Int Immunol. 2008;20(9):1181\u20137.","journal-title":"Int Immunol"},{"issue":"11","key":"620_CR75","doi-asserted-by":"publisher","first-page":"6732","DOI":"10.4049\/jimmunol.174.11.6732","volume":"174","author":"JO Manilay","year":"2005","unstructured":"Manilay JO, Anderson AC, Kang C, Robey EA. Impairment of thymocyte development by dominant-negative Kuzbanian (ADAM-10) is rescued by the Notch ligand, Delta-11. J Immunol. 2005;174(11):6732\u201341.","journal-title":"J Immunol"},{"issue":"3","key":"620_CR76","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/ni.2538","volume":"14","author":"CS Guy","year":"2013","unstructured":"Guy CS, Vignali KM, Temirov J, Bettini ML, Overacre AE, Smeltzer M, et al. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nat Immunol. 2013;14(3):262\u201370.","journal-title":"Nat Immunol"},{"key":"620_CR77","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","volume":"40","author":"A Roy","year":"2016","unstructured":"Roy A, Srivastava M, Saqib U, Liu D, Faisal SM, Sugathan S, et al. Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways. Int Immunopharmacol. 2016;40:79\u201389.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"620_CR78","doi-asserted-by":"publisher","first-page":"030006052092791","DOI":"10.1177\/0300060520927919","volume":"48","author":"F Zhang","year":"2020","unstructured":"Zhang F, Ma H, Wang ZL, Li WH, Liu H, Zhao YX. The PI3K\/AKT\/mTOR pathway regulates autophagy to induce apoptosis of alveolar epithelial cells in chronic obstructive pulmonary disease caused by PM2.5 particulate matter. J Int Med Res. 2020;48(7):0300060520927919.","journal-title":"J Int Med Res"},{"issue":"2","key":"620_CR79","first-page":"69","volume":"68","author":"AN Be\u015fliu","year":"2009","unstructured":"Be\u015fliu AN, Pistol G, Marica CM, B\u0103nic\u0103 LM, Chi\u0163onu C, Ionescu R, et al. PI3K\/Akt signaling in peripheral T lymphocytes from systemic lupus erythematosus patients. Roum Arch Microbiol Immunol. 2009;68(2):69\u201379.","journal-title":"Roum Arch Microbiol Immunol"},{"key":"620_CR80","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejphar.2014.04.024","volume":"735","author":"S Park","year":"2014","unstructured":"Park S, Regmi SC, Park SY, Lee EK, Chang JH, Ku SK, et al. Protective effect of 7-O-succinyl macrolactin A against intestinal inflammation is mediated through PI3-kinase\/Akt\/mTOR and NF-\u03baB signaling pathways. Eur J Pharmacol. 2014;735:184\u201392.","journal-title":"Eur J Pharmacol"},{"key":"620_CR81","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.fitote.2016.11.010","volume":"116","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Pollastro F, Grassi G, Bramanti P, Mazzon E. Target regulation of PI3K\/Akt\/mTOR pathway by Cannabidiol in treatment of experimental multiple sclerosis. Fitoterapia. 2017;116:77\u201384.","journal-title":"Fitoterapia"},{"issue":"20","key":"620_CR82","doi-asserted-by":"publisher","first-page":"19757","DOI":"10.1074\/jbc.M413516200","volume":"280","author":"A Hurbin","year":"2005","unstructured":"Hurbin A, Coll JL, Dubrez-Daloz L, Mari B, Auberger P, Brambilla C, et al. Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax-and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J Biol Chem. 2005;280(20):19757\u201367.","journal-title":"J Biol Chem"},{"issue":"10","key":"620_CR83","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1021\/bi0477687","volume":"44","author":"A Antignani","year":"2005","unstructured":"Antignani A, Youle RJ. A chimeric protein induces tumor cell apoptosis by delivering the human Bcl-2 family BH3-only protein bad. Biochemistry. 2005;44(10):4074\u201382.","journal-title":"Biochemistry"},{"issue":"3","key":"620_CR84","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1128\/IAI.73.3.1399-1403.2005","volume":"73","author":"S Ying","year":"2005","unstructured":"Ying S, Seiffert BM, H\u00e4cker G, Fischer SF. Broad degradation of proapoptotic proteins with the conserved Bcl-2 homology domain 3 during infection with chlamydia trachomatis. Infect Immun. 2005;73(3):1399\u2013403.","journal-title":"Infect Immun"},{"issue":"40","key":"620_CR85","doi-asserted-by":"publisher","first-page":"42240","DOI":"10.1074\/jbc.M406775200","volume":"279","author":"SY Seo","year":"2004","unstructured":"Seo SY, Chen Yb, Ivanovska I, Ranger AM, Hong SJ, Dawson VL, et al. BAD is a pro-survival factor prior to activation of its pro-apoptotic function. J Biol Chem. 2004;279(40):42240\u20139.","journal-title":"J Biol Chem"},{"issue":"8","key":"620_CR86","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/carcin\/bgh145","volume":"25","author":"JW Lee","year":"2004","unstructured":"Lee JW, Soung YH, Kim SY, Nam SW, Kim CJ, Cho YG, et al. Inactivating mutations of proapoptotic bad gene in human colon cancers. Carcinogenesis. 2004;25(8):1371\u20136.","journal-title":"Carcinogenesis"},{"issue":"45","key":"620_CR87","doi-asserted-by":"publisher","first-page":"E10682","DOI":"10.1073\/pnas.1808217115","volume":"115","author":"M Chen","year":"2018","unstructured":"Chen M, Yan R, Zhou K, Li X, Zhang Y, Liu C, et al. Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia. Proc Natl Acad Sci U S A. 2018;115(45):E10682\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"620_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2024.109210","volume":"244","author":"S Zhang","year":"2024","unstructured":"Zhang S, Sun C, Huang Q, Du J, Xia Y, Zhou K, et al. The role of protein kinase C and the glycoprotein Ib\u03b1 cytoplasmic tail in anti-glycoprotein Ib\u03b1 antibody-induced platelet apoptosis and thrombocytopenia. Thromb Res. 2024;244:109210.","journal-title":"Thromb Res"},{"issue":"9","key":"620_CR89","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1111\/jth.14214","volume":"16","author":"DF Zeng","year":"2018","unstructured":"Zeng DF, Chen F, Wang S, Chen SL, Xu Y, Shen MQ, et al. Autoantibody against integrin \u03b1v\u03b23 contributes to thrombocytopenia by blocking the migration and adhesion of megakaryocytes. J Thromb Haemost. 2018;16(9):1843\u201356.","journal-title":"J Thromb Haemost"},{"issue":"12","key":"620_CR90","doi-asserted-by":"publisher","first-page":"E228","DOI":"10.1002\/ajh.23832","volume":"89","author":"WB Mitchell","year":"2014","unstructured":"Mitchell WB, Pinheiro MP, Boulad N, Kaplan D, Edison MN, Psaila B, et al. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia. Am J Hematol. 2014;89(12):E228\u201334.","journal-title":"Am J Hematol"},{"issue":"12","key":"620_CR91","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3324\/haematol.2016.146746","volume":"101","author":"CA Di Buduo","year":"2016","unstructured":"Di Buduo CA, Currao M, Pecci A, Kaplan DL, Balduini CL, Balduini A. Revealing eltrombopag\u2019s promotion of human megakaryopoiesis through AKT\/ERK-dependent pathway activation. Haematologica. 2016;101(12):1479\u201388.","journal-title":"Haematologica"},{"issue":"2","key":"620_CR92","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11912-020-01008-4","volume":"23","author":"L Dennison","year":"2021","unstructured":"Dennison L, Mohan AA, Yarchoan M. Tumor and systemic immunomodulatory effects of MEK inhibition. Curr Oncol Rep. 2021;23(2):23.","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"620_CR93","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1128\/MMBR.00043-14","volume":"80","author":"A Zeke","year":"2016","unstructured":"Zeke A, Misheva M, Rem\u00e9nyi A, Bogoyevitch MA. JNK signaling: regulation and functions based on complex protein-protein partnerships. Microbiol Mol Biol Rev. 2016;80(3):793\u2013835.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"6782","key":"620_CR94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/35011091","volume":"405","author":"C Dong","year":"2000","unstructured":"Dong C, Yang DD, Tournier C, Whitmarsh AJ, Xu J, Davis RJ, et al. JNK is required for effector T-cell function but not for T-cell activation. Nature. 2000;405(6782):91\u20134.","journal-title":"Nature"},{"issue":"1","key":"620_CR95","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00744.x","volume":"228","author":"M Rinc\u00f3n","year":"2009","unstructured":"Rinc\u00f3n M, Davis RJ. Regulation of the immune response by stress-activated protein kinases. Immunol Rev. 2009;228(1):212\u201324.","journal-title":"Immunol Rev"},{"issue":"7","key":"620_CR96","doi-asserted-by":"publisher","first-page":"e32947","DOI":"10.1097\/MD.0000000000032947","volume":"102","author":"JS Ruan","year":"2023","unstructured":"Ruan JS, Sun RJ, Wang JP, Sui XH, Qu HT, Yuan D, et al. Gene mutations in the PI3K\/Akt signaling pathway were related to immune thrombocytopenia pathogenesis. Medicine. 2023;102(7):e32947.","journal-title":"Medicine"},{"issue":"11","key":"620_CR97","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1161\/ATVBAHA.117.309751","volume":"37","author":"Y Liu","year":"2017","unstructured":"Liu Y, Hu M, Luo D, Yue M, Wang S, Chen X, et al. Class III PI3K positively regulates platelet activation and thrombosis via PI(3)P-directed function of NADPH oxidase. Arterioscler Thromb Vasc Biol. 2017;37(11):2075\u201386.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"620_CR98","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/jth.12954","volume":"13","author":"AJ Moroi","year":"2015","unstructured":"Moroi AJ, Watson SP. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3\u03b1\/\u03b2. J Thromb Haemost. 2015;13(6):1139\u201350.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"620_CR99","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1182\/blood-2013-07-516336","volume":"123","author":"JM Speth","year":"2014","unstructured":"Speth JM, Hoggatt J, Singh P, Pelus LM. Pharmacologic increase in HIF1\u03b1 enhances hematopoietic stem and progenitor homing and engraftment. Blood. 2014;123(2):203\u20137.","journal-title":"Blood"},{"issue":"23","key":"620_CR100","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","volume":"113","author":"JF DiPersio","year":"2009","unstructured":"DiPersio JF, Stadtmauer EA, Nademanee A, Micallef INM, Stiff PJ, Kaufman JL, et al. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood. 2009;113(23):5720\u20136.","journal-title":"Blood"},{"issue":"10","key":"620_CR101","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1055\/s-0039-1694030","volume":"117","author":"J Qi","year":"2017","unstructured":"Qi J, You T, Pan T, Wang Q, Zhu L, Han Y. Downregulation of hypoxia-inducible factor-1\u03b1 contributes to impaired megakaryopoiesis in immune thrombocytopenia. Thromb Haemost. 2017;117(10):1875\u201386.","journal-title":"Thromb Haemost"},{"key":"620_CR102","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fimmu.2021.633586","volume":"12","author":"M Gojkovic","year":"2021","unstructured":"Gojkovic M, Cunha PP, Darmasaputra GS, Barbieri L, Rundqvist H, Veli\u00e7a P, et al. Oxygen-mediated suppression of CD8\u2009+\u2009T cell proliferation by macrophages: role of pharmacological inhibitors of HIF degradation. Front Immunol. 2021;12:2021.","journal-title":"Front Immunol"},{"key":"620_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.107188","volume":"102","author":"W Jianfang","year":"2022","unstructured":"Jianfang W, Hui W, Le K. LINC00870 regulates Th1\/Th2 via the JAK\/STAT pathway in peripheral blood mononuclear cells infected with mycobacterium tuberculosis. Int Immunopharmacol. 2022;102:107188.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"620_CR104","first-page":"859","volume":"26","author":"Z Xi","year":"2018","unstructured":"Xi Z, Hai B, Xiaohui Y, Bing W, YaoZhu P, Cunbang W, et al. Changes of IL-21 and its mediated JAK\/STAT signaling pathway in patients with immune thrombocytopenia. J Experimental Hematol. 2018;26(3):859\u201365.","journal-title":"J Experimental Hematol"},{"issue":"21","key":"620_CR105","first-page":"3257","volume":"38","author":"X Jianhong","year":"2017","unstructured":"Jianhong X, Junjun L, Yunxian C, Feng W, Zeyu L, Yuxiong C, et al. The roles of CD4\u2009+\u2009T cell and its activating transcription factor STAT4\/6 in immune thrombocytopenic purpura. Guangdong Med J. 2017;38(21):3257\u201360.","journal-title":"Guangdong Med J"},{"issue":"05","key":"620_CR106","first-page":"1570","volume":"29","author":"S Yan","year":"2021","unstructured":"Yan S, Mingjing W, Xintian C, Weiyi L, Haiyan C, Xiaoqing D, et al. Expression of MicroRNAs in peripheral blood of patients with primary immune thrombocytopenia and its correlation with the imbalance of Th1\/Th2 cell. J Experimental Hematol. 2021;29(05):1570\u20136.","journal-title":"J Experimental Hematol"},{"issue":"9","key":"620_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094864","volume":"25","author":"A Balykina","year":"2024","unstructured":"Balykina A, Naida L, Kirkg\u00f6z K, Nikolaev VO, Fock E, Belyakov M, et al. Antiplatelet effects of flavonoid aglycones are mediated by activation of cyclic nucleotide-dependent protein kinases. Int J Mol Sci. 2024;25(9):4864.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"620_CR108","doi-asserted-by":"publisher","DOI":"10.1155\/mi\/6393872","volume":"2024","author":"QY Lu","year":"2024","unstructured":"Lu QY, Guo L, Zhang QY, Yang FM, Zhou ST, Sun QY. Luteolin alleviates the TNF-\u03b1-induced inflammatory response of human microvascular endothelial cells via the Akt\/MAPK\/NF-\u03baB pathway. Mediators Inflamm. 2024;2024(1):6393872.","journal-title":"Mediators Inflamm"},{"issue":"05","key":"620_CR109","first-page":"519","volume":"33","author":"H Shengdi","year":"2021","unstructured":"Shengdi H, Xin W, Jingai P, Mingjie X. Liteolin maintains the stability of blood circulation function by promoting the content of coagulation active substances and coagulation factors. Chin J Microecol. 2021;33(05):519\u201323.","journal-title":"Chin J Microecol"},{"key":"620_CR110","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jff.2018.07.037","volume":"48","author":"D Kashyap","year":"2018","unstructured":"Kashyap D, Sharma A, Tuli HS, Sak K, Garg VK, Buttar HS, et al. Apigenin: a natural bioactive flavone-type molecule with promising therapeutic function. J Funct Foods. 2018;48:457\u201371.","journal-title":"J Funct Foods"},{"issue":"4","key":"620_CR111","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3746\/pnf.2017.22.4.320","volume":"22","author":"GD Kim","year":"2017","unstructured":"Kim GD. Kaempferol inhibits angiogenesis by suppressing HIF-1\u03b1 and VEGFR2 activation via ERK\/p38 MAPK and PI3K\/Akt\/mTOR signaling pathways in endothelial cells. Prev Nutr Food Sci. 2017;22(4):320\u20136.","journal-title":"Prev Nutr Food Sci"},{"issue":"3","key":"620_CR112","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1476-5381.2011.01389.x","volume":"164","author":"S Park","year":"2011","unstructured":"Park S, Sapkota K, Kim S, Kim H, Kim S. Kaempferol acts through mitogen-activated protein kinases and protein kinase B\/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells. Br J Pharmacol. 2011;164(3):1008\u201325.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"620_CR113","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10753-014-0011-2","volume":"38","author":"XL Tang","year":"2015","unstructured":"Tang XL, Liu JX, Dong W, Li P, Li L, Hou JC, et al. Protective effect of kaempferol on LPS plus ATP-induced inflammatory response in cardiac fibroblasts. Inflammation. 2015;38(1):94\u2013101.","journal-title":"Inflammation"},{"key":"620_CR114","doi-asserted-by":"publisher","DOI":"10.1093\/ecam\/nep066","volume":"2011","author":"WF Chiou","year":"2011","unstructured":"Chiou WF, Chen CC, Wei BL. 8-Prenylkaempferol suppresses influenza a virus-Induced RANTES production in A549 cells via blocking PI3K-mediated transcriptional activation of NF-\u03baB and IRF3. Evid Based Complement Alternat Med. 2011;2011:920828.","journal-title":"Evid Based Complement Alternat Med"},{"key":"620_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103533","author":"J Chen","year":"2025","unstructured":"Chen J, Liu H, Fu Y, Chen X, Zhang S, Yang Y, et al. Kaempferol attenuates macrophage M1 polarization and liver fibrosis by inhibiting mitogen-activated protein kinase\/nuclear factor \u03baB signaling pathway. J Pharmacol Exp Ther. 2025. https:\/\/doi.org\/10.1016\/j.jpet.2025.103533.","journal-title":"J Pharmacol Exp Ther"},{"key":"620_CR116","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2015.04.008","volume":"97","author":"WR Garc\u00eda-Ni\u00f1o","year":"2015","unstructured":"Garc\u00eda-Ni\u00f1o WR, Zazueta C. Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection. Pharmacol Res. 2015;97:84\u2013103.","journal-title":"Pharmacol Res"},{"issue":"15","key":"620_CR117","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1055\/a-0633-9492","volume":"84","author":"JL R\u00edos","year":"2018","unstructured":"R\u00edos JL, Giner RM, Mar\u00edn M, Recio MC. A pharmacological update of ellagic acid. Planta Med. 2018;84(15):1068\u201393.","journal-title":"Planta Med"},{"issue":"1","key":"620_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-022-00323-1","volume":"48","author":"X Wang","year":"2023","unstructured":"Wang X, Huang M, Xie W, Ding Q, Wang T. Eupafolin regulates non-small-cell lung cancer cell proliferation, migration, and invasion by suppressing MMP9 and RhoA via FAK\/PI3K\/AKT signaling pathway. J Biosci. 2023;48(1):1.","journal-title":"J Biosci"},{"issue":"04","key":"620_CR119","first-page":"507","volume":"54","author":"L Shuixia","year":"2023","unstructured":"Shuixia L, Jinghua C, Dan W, Xuli Z, Xudong G, Yuxiang Z, An L. Eupafolin attenuates inflammation in rats with secretory otitis media through p38 MAPK signaling pathway. J Shanxi Med Univ. 2023;54(04):507\u201314.","journal-title":"J Shanxi Med Univ"},{"key":"620_CR120","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.2147\/JIR.S393850","volume":"16","author":"Y Lu","year":"2023","unstructured":"Lu Y, Li D, Huang Y, Sun Y, Zhou H, Ye F, et al. Pretreatment with eupatilin attenuates inflammation and coagulation in sepsis by suppressing JAK2\/STAT3 signaling pathway. J Inflamm Res. 2023;16:1027\u201342.","journal-title":"J Inflamm Res"},{"key":"620_CR121","unstructured":"Ruting X, Xiaoxuan L, Jing Z, editors. Metabonomics study on ellagic acid from sanguisorba officinalis for promoting platelet production. 2018 China Mass Spectrometry Conference(CMSC 2018). Guangzhou: 2018:306. (in Chinese)"},{"issue":"4","key":"620_CR122","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.3390\/molecules19045448","volume":"19","author":"X Gao","year":"2014","unstructured":"Gao X, Wu J, Zou W, Dai Y. Two ellagic acids isolated from roots of Sanguisorba officinalis L. promote hematopoietic progenitor cell proliferation and megakaryocyte differentiation. Molecules. 2014;19(4):5448\u201358.","journal-title":"Molecules"},{"issue":"6","key":"620_CR123","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.7150\/ijbs.90483","volume":"20","author":"X Tang","year":"2024","unstructured":"Tang X, Liao R, Zhou L, Yi T, Ran M, Luo J, et al. Genistin: a novel estrogen analogue targeting ER\u03b2 to alleviate thrombocytopenia. Int J Biol Sci. 2024;20(6):2236\u201360.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"620_CR124","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1200\/JCO.18.00053","volume":"37","author":"ME Horwitz","year":"2019","unstructured":"Horwitz ME, Wease S, Blackwell B, Valcarcel D, Frassoni F, Boelens JJ, et al. Phase I\/II study of stem-cell transplantation using a single cord blood unit expanded ex vivo with nicotinamide. J Clin Oncol. 2019;37(5):367\u201374.","journal-title":"J Clin Oncol"},{"issue":"16","key":"620_CR125","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1182\/blood.2021011719","volume":"138","author":"ME Horwitz","year":"2021","unstructured":"Horwitz ME, Stiff PJ, Cutler C, Brunstein C, Hanna R, Maziarz RT, et al. Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study. Blood. 2021;138(16):1429\u201340.","journal-title":"Blood"},{"issue":"1","key":"620_CR126","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-025-00709-9","volume":"23","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lin Y, Hong J, Wang J, Li B, Liu Z, et al. Oroxylin a reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation. Thromb J. 2025;23(1):26.","journal-title":"Thromb J"},{"key":"620_CR127","doi-asserted-by":"publisher","first-page":"1508215","DOI":"10.3389\/fphar.2025.1508215","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Li Q, Wu S, Mei X, Qi X, Liu S, et al. Regulating mitochondrial oxidative phosphorylation and MAPK signaling: wedelolactone as a novel therapeutic for radiation-induced thrombocytopenia. Front Pharmacol. 2025;16:1508215.","journal-title":"Front Pharmacol"},{"issue":"1","key":"620_CR128","first-page":"14","volume":"25","author":"Z Hu","year":"2022","unstructured":"Hu Z, Guan Y, Hu W, Xu Z, Ishfaq M. An overview of pharmacological activities of Baicalin and its aglycone baicalein: new insights into molecular mechanisms and signaling pathways. Iran J Basic Med Sci. 2022;25(1):14\u201326.","journal-title":"Iran J Basic Med Sci"},{"key":"620_CR129","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jep.2014.08.031","volume":"156","author":"M Li","year":"2014","unstructured":"Li M, Shi A, Pang H, Xue W, Li Y, Cao G, et al. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. J Ethnopharmacol. 2014;156:210\u20135.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"620_CR130","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"L Yong","year":"2008","unstructured":"Yong L, Ranxin S, Xia W, Han-Ming S. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets. 2008;8(7):634\u201346.","journal-title":"Curr Cancer Drug Targets"},{"key":"620_CR131","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4137\/JEN.S25096","volume":"10","author":"GAE Shoubaky","year":"2016","unstructured":"Shoubaky GAE, Abdel-Daim MM, Mansour MH, Salem EA. Isolation and identification of a flavone apigenin from marine red alga acanthophora spicifera with antinociceptive and anti-inflammatory activities. J Exp Neurosci. 2016;10:21\u20139.","journal-title":"J Exp Neurosci"},{"issue":"3","key":"620_CR132","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0165-1218(90)90060-F","volume":"240","author":"H Czeczot","year":"1990","unstructured":"Czeczot H, Tudek B, Kusztelak J, Szymczyk T, Dobrowolska B, Glinkowska G, et al. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat Res-Genet Toxicol. 1990;240(3):209\u201316.","journal-title":"Mutat Res-Genet Toxicol"},{"key":"620_CR133","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jcis.2015.04.030","volume":"453","author":"K Banerjee","year":"2015","unstructured":"Banerjee K, Banerjee S, Das S, Mandal M. Probing the potential of apigenin liposomes in enhancing bacterial membrane perturbation and integrity loss. J Colloid Interface Sci. 2015;453:48\u201359.","journal-title":"J Colloid Interface Sci"},{"issue":"2","key":"620_CR134","doi-asserted-by":"publisher","first-page":"e31964","DOI":"10.1371\/journal.pone.0031964","volume":"7","author":"P Singh","year":"2012","unstructured":"Singh P, Mishra SK, Noel S, Sharma S, Rath SK. Acute exposure of apigenin induces hepatotoxicity in Swiss mice. PLoS One. 2012;7(2):e31964.","journal-title":"PLoS One"},{"issue":"1","key":"620_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2011-y","volume":"21","author":"A Rey","year":"2019","unstructured":"Rey A, Batteux B, Laville SM, Marienne J, Masmoudi K, Gras-Champel V, et al. Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study. Arthritis Res Ther. 2019;21(1):229.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"620_CR136","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7326\/0003-4819-86-2-196","volume":"86","author":"DR Gelbart","year":"1977","unstructured":"Gelbart DR, Weinstein AB, Fajardo LF. Allopurinol-induced interstitial nephritis. Ann Intern Med. 1977;86(2):196\u20138.","journal-title":"Ann Intern Med"},{"issue":"1","key":"620_CR137","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tox.2007.03.018","volume":"235","author":"WH Park","year":"2007","unstructured":"Park WH, Han YH, Kim SH, Kim SZ. Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via cell cycle arrest of G2 phase and apoptosis. Toxicology. 2007;235(1):130\u20139.","journal-title":"Toxicology"},{"issue":"3","key":"620_CR138","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/00005373-200109000-00003","volume":"51","author":"S Kerkar","year":"2001","unstructured":"Kerkar S, Speyer C, Tyburski J, Steffes C. Reactive oxygen metabolites induce a biphasic contractile response in microvascular lung pericytes. J Trauma Acute Care Surg. 2001;51(3):440\u20135.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"620_CR139","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.tiv.2008.06.014","volume":"22","author":"YH Han","year":"2008","unstructured":"Han YH, Kim SZ, Kim SH, Park WH. Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest. Toxicol in Vitro. 2008;22(6):1605\u20139.","journal-title":"Toxicol in Vitro"},{"issue":"3","key":"620_CR140","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.lungcan.2007.08.034","volume":"59","author":"YH Han","year":"2008","unstructured":"Han YH, Kim SZ, Kim SH, Park WH. Apoptosis in pyrogallol-treated calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels. Lung Cancer. 2008;59(3):301\u201314.","journal-title":"Lung Cancer"},{"issue":"1","key":"620_CR141","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chroma.2003.09.009","volume":"1032","author":"T-H Tsai","year":"2004","unstructured":"Tsai T-H, Liu M-C. Determination of unbound theophylline in rat blood and brain by microdialysis and liquid chromatography. J Chromatogr A. 2004;1032(1):97\u2013101.","journal-title":"J Chromatogr A"},{"issue":"1","key":"620_CR142","first-page":"171756","volume":"2015","author":"TC Diniz","year":"2015","unstructured":"Diniz TC, Silva JC, Lima-Saraiva SRGd, Ribeiro FPRA, Pacheco AGM, de Freitas RM, et al. The role of flavonoids on oxidative stress in epilepsy. Oxidative Med Cell Longev. 2015;2015(1):171756.","journal-title":"Oxidative Med Cell Longev"},{"issue":"9","key":"620_CR143","first-page":"1077","volume":"27","author":"M Saeed","year":"2024","unstructured":"Saeed M, Magaji RA, Magaji MG, Gaya IB, Umar B, Yusha\u2019u Y, et al. Neuroprotective roles of flavonoid Hispidulin in the central nervous system: a review. Iran J Basic Med Sci. 2024;27(9):1077\u201384.","journal-title":"Iran J Basic Med Sci"},{"issue":"11","key":"620_CR144","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s001250051536","volume":"43","author":"M Knip","year":"2000","unstructured":"Knip M, Douek IF, Moore WPT, Gillmor HA, McLean AEM, Bingley PJ, et al. Safety of high-dose nicotinamide: a review. Diabetologia. 2000;43(11):1337\u201345.","journal-title":"Diabetologia"},{"issue":"11","key":"620_CR145","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep4.1253","volume":"2","author":"K Leung","year":"2018","unstructured":"Leung K, Quezada M, Chen Z, Kanel G, Kaplowitz N. Niacin-induced anicteric microvesicular steatotic acute liver failure. Hepatol Commun. 2018;2(11):1293\u20138.","journal-title":"Hepatol Commun"},{"issue":"6","key":"620_CR146","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.21037\/apm-21-1067","volume":"10","author":"P Zhang","year":"2021","unstructured":"Zhang P, Miao W. Eltrombopag-induced liver dysfunction during the treatment of immune thrombocytopenia and its risk factors. Ann Palliat Med. 2021;10(6):6419\u201324.","journal-title":"Ann Palliat Med"},{"key":"620_CR147","volume-title":"Clinical and research information on drug-Induced liver injury","author":"LiverTox","year":"2012","unstructured":"LiverTox. Clinical and research information on drug-Induced liver injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"18","key":"620_CR148","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.1182\/blood-2009-05-224766","volume":"114","author":"DJ Kuter","year":"2009","unstructured":"Kuter DJ, Mufti GJ, Bain BJ, Hasserjian RP, Davis W, Rutstein M. Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with Romiplostim. Blood. 2009;114(18):3748\u201356.","journal-title":"Blood"},{"key":"620_CR149","doi-asserted-by":"publisher","first-page":"820969","DOI":"10.3389\/fphar.2022.820969","volume":"13","author":"YX Goh","year":"2022","unstructured":"Goh YX, Jalil J, Lam KW, Husain K, Premakumar CM. Genistein: a review on its anti-inflammatory properties. Front Pharmacol. 2022;13:820969.","journal-title":"Front Pharmacol"},{"issue":"14","key":"620_CR150","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1055\/s-0028-1088314","volume":"74","author":"G Seelinger","year":"2008","unstructured":"Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and anti-allergic activities of Luteolin. Planta Med. 2008;74(14):1667\u201377.","journal-title":"Planta Med"},{"issue":"15","key":"620_CR151","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.3390\/molecules28155904","volume":"28","author":"J Rong","year":"2023","unstructured":"Rong J, Fu F, Han C, Wu Y, Xia Q, Du D. Tectorigenin: a review of its sources, pharmacology, toxicity, and pharmacokinetics. Molecules. 2023;28(15):5904.","journal-title":"Molecules"},{"key":"620_CR152","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jep.2016.05.002","volume":"189","author":"CW Lee","year":"2016","unstructured":"Lee CW, Lin ZC, Hsu LF, Fang JY, Chiang YC, Tsai MH, et al. Eupafolin ameliorates COX-2 expression and PGE2 production in particulate pollutants-exposed human keratinocytes through ROS\/MAPKs pathways. J Ethnopharmacol. 2016;189:300\u20139.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"620_CR153","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tem.2023.01.005","volume":"34","author":"Jl Ren","year":"2023","unstructured":"Ren Jl, Yang L, Qiu S, Zhang AH, Wang XJ. Efficacy evaluation, active ingredients, and multitarget exploration of herbal medicine. Trends Endocrinol Metab. 2023;34(3):146\u201357.","journal-title":"Trends Endocrinol Metab"},{"key":"620_CR154","first-page":"4","volume":"26","author":"Z Wenxia","year":"2012","unstructured":"Wenxia Z, Xiaorui C, Yongxiang Z. Network pharmacology - a new philosophy for understanding of drug action and discovery of new drugs. Chin J Pharmacol Toxicol. 2012;26:4\u20139.","journal-title":"Chin J Pharmacol Toxicol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00620-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00620-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:09:44Z","timestamp":1768342184000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00620-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":154,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00620-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and approval were not required for this study in accordance with the local legislation and institutional requirements, as this study did not involve human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}